Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials

被引：136

作者：

Peeters, M

Toure-Kane, C

Nkengasong, JN

机构：

[1] Inst Rech Dev, UR36, F-34394 Montpellier 1, France

[2] Hop Dantec, Virol Lab, Dakar, Senegal

[3] Projet RETRO CI, Abidjan, Cote Ivoire

[4] Natl Ctr HIV STD & TB Prevent, Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA

来源：

AIDS | 2003年 / 17卷 / 18期

关键词：

D O I：

10.1097/00002030-200312050-00002

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2547 / 2560

页数：14

共 158 条

[1]

Adjé C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018

[2] Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials [J].

Agwale, SM ;

Zeh, C ;

Robbins, KE ;

Odama, L ;

Saekhou, A ;

Edubio, A ;

Njoku, M ;

Sani-Gwarzo, N ;

Gboun, MS ;

Gao, F ;

Reitz, M ;

Hone, D ;

Pieniazek, D ;

Wambebe, C ;

Kalish, ML .

VACCINE, 2002, 20 (16) :2131-2139

[3] Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D [J].

Alaeus, A ;

Lidman, K ;

Björkman, A ;

Giesecke, J ;

Albert, J .

AIDS, 1999, 13 (08) :901-907

[4] Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02) [J].

Amendola, A ;

Bordi, L ;

Angeletti, C ;

Visco-Comandini, U ;

Abbate, I ;

Cappiello, G ;

Budabbus, MA ;

Eljhawi, OA ;

Mehabresh, MI ;

Girardi, E ;

Antinori, A ;

Ippolito, G ;

Capobianchi, MR .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (05) :488-494

[5] Molecular characterization of human immunodeficiency virus (HIV)-1 and-2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa [J].

Andersson, S ;

Norrgren, H ;

Dias, F ;

Biberfeld, G ;

Albert, J .

VIROLOGY, 1999, 262 (02) :312-320

[6] Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility [J].

Apetrei, C ;

Descamps, D ;

Collin, G ;

Loussert-Ajaka, I ;

Damond, F ;

Duca, M ;

Simon, F ;

Brun-Vézinet, F .

JOURNAL OF VIROLOGY, 1998, 72 (05) :3534-3538

[7] Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions [J].

Apetrei, C ;

LoussertAjaka, I ;

Descamps, D ;

Damond, F ;

Saragosti, S ;

BrunVezinet, F ;

Simon, F .

AIDS, 1996, 10 (14) :F57-F60

[8] HIV-1 group N among HIV-1-seropositive individuals in Cameroon [J].

Ayouba, A ;

Souquières, S ;

Njinku, B ;

Martin, PMV ;

Müller-Trutwin, MC ;

Roques, P ;

Barré-Sinoussi, F ;

Mauclère, P ;

Simon, F ;

Nerrienet, E .

AIDS, 2000, 14 (16) :2623-2625

[9] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].

BARRESINOUSSI, F ;

CHERMANN, JC ;

REY, F ;

NUGEYRE, MT ;

CHAMARET, S ;

GRUEST, J ;

DAUGUET, C ;

AXLERBLIN, C ;

VEZINETBRUN, F ;

ROUZIOUX, C ;

ROZENBAUM, W ;

MONTAGNIER, L .

SCIENCE, 1983, 220 (4599) :868-871

[10] HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe [J].

Batra, M ;

Tien, PC ;

Shafer, RW ;

Contag, CH ;

Katzenstein, DA .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (10) :973-979

← 1 2 3 4 5 6 7 8 9 10 →